387 related articles for article (PubMed ID: 17998021)
1. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
Kita Y; Mizukoshi E; Takamura T; Sakurai M; Takata Y; Arai K; Yamashita T; Nakamoto Y; Kaneko S
Metabolism; 2007 Dec; 56(12):1682-8. PubMed ID: 17998021
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
4. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
Di Costanzo GG; De Luca M; Tritto G; Lampasi F; Addario L; Lanza AG; Tartaglione MT; Picciotto FP; Ascione A
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):674-9. PubMed ID: 18679071
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.
Hu SX; Kyulo NL; Xia VW; Hillebrand DJ; Hu KQ
J Clin Gastroenterol; 2009 Sep; 43(8):758-64. PubMed ID: 19238091
[TBL] [Abstract][Full Text] [Related]
6. Contribution of obesity to hepatitis C-related fibrosis progression.
Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
[TBL] [Abstract][Full Text] [Related]
7. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
8. Natural history of chronic hepatitis C.
Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
[TBL] [Abstract][Full Text] [Related]
9. The natural history of hepatitis C.
Afdhal NH
Semin Liver Dis; 2004; 24 Suppl 2():3-8. PubMed ID: 15346240
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
[TBL] [Abstract][Full Text] [Related]
11. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
12. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
13. A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.
Azzaroli F; Colecchia A; Lodato F; Trerè D; Bacchi Reggiani ML; Festi D; Prati GM; Accogli E; Casanova S; Derenzini M; Roda E; Mazzella G
Aliment Pharmacol Ther; 2006 Jul; 24(1):129-36. PubMed ID: 16803611
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
15. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
16. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.
Elkrief L; Chouinard P; Bendersky N; Hajage D; Larroque B; Babany G; Kutala B; Francoz C; Boyer N; Moreau R; Durand F; Marcellin P; Rautou PE; Valla D
Hepatology; 2014 Sep; 60(3):823-31. PubMed ID: 24841704
[TBL] [Abstract][Full Text] [Related]
18. Narcotic analgesics and progression of fibrosis in patients with chronic hepatitis C.
Vallejos C; Bordin-Wosk T; Pockros L; Feng A; Pockros P
J Clin Gastroenterol; 2009 Apr; 43(4):357-61. PubMed ID: 19034042
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
Ohishi W; Fujiwara S; Cologne JB; Suzuki G; Akahoshi M; Nishi N; Takahashi I; Chayama K
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
[TBL] [Abstract][Full Text] [Related]
20. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation.
Shiffman ML
Liver Transpl; 2003 Nov; 9(11):S14-20. PubMed ID: 14586890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]